Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.191
+0.013 (7.13%)
Nov 21, 2024, 12:30 PM EST - Market open

Lyra Therapeutics Revenue

Lyra Therapeutics had revenue of $195.00K in the quarter ending September 30, 2024, a decrease of -64.15%. This brings the company's revenue in the last twelve months to $1.47M, up 3.37% year-over-year. In the year 2023, Lyra Therapeutics had annual revenue of $1.56M with 14.31% growth.

Revenue (ttm)
$1.47M
Revenue Growth
+3.37%
P/S Ratio
7.76
Revenue / Employee
$16,716
Employees
88
Market Cap
12.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.56M195.00K14.31%
Dec 31, 20221.36M1.08M378.25%
Dec 31, 2021285.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
China Jo-Jo Drugstores 154.54M
Trinity Biotech 59.13M
ImmunoPrecise Antibodies 17.44M
Aspira Women's Health 8.96M
QT Imaging Holdings 4.04M
PAVmed 4.03M
Immuron 3.27M
Talphera 281.00K
Revenue Rankings